View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

KRONOS WORLDWIDE, INC. REPORTS FIRST QUARTER 2024 RESULTS

KRONOS WORLDWIDE, INC. REPORTS FIRST QUARTER 2024 RESULTS Dallas, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Kronos Worldwide, Inc. (NYSE:KRO) today reported net income of $8.1 million, or $.07 per share, in the first quarter of 2024 compared to a net loss of $15.2 million, or $.13 per share, in the first quarter of 2023. Net income increased in the first quarter of 2024 as compared to the first quarter of 2023 primarily due to higher income from operations as a result of the net effect of higher sales and production volumes, lower average TiO2 selling prices and lower production costs (prim...

 PRESS RELEASE

PennantPark Floating Rate Capital Ltd. Announces Financial Results for...

PennantPark Floating Rate Capital Ltd. Announces Financial Results for the Quarter Ended March 31, 2024 MIAMI, May 08, 2024 (GLOBE NEWSWIRE) --  PennantPark Floating Rate Capital Ltd. (NYSE: PFLT) announced today its financial results for the second quarter ended March 31, 2024. HIGHLIGHTSQuarter ended March 31, 2024 (Unaudited)($ in millions, except per share amounts) Assets and Liabilities:     Investment portfolio (1)   $1,477.9 Net assets   $720.7 GAAP net asset value per share   $11.40 Quarterly increase in GAAP net asset value per share    1.8%Adjusted net asset value per share (2)...

Valens Research
  • Valens Research

PBF - Valens Credit Report - 2024 04 22

Credit markets are overstating credit risk with a YTW of 6.853% relative to an Intrinsic YTW of 6.083% and an Intrinsic CDS of 139bps. Meanwhile, credit markets are materially overstating the firm's fundamental credit risk, with its Ba3 credit rating five notches lower than Valens' IG4+ (Baa1) credit rating. Incentives Dictate Behavior™ analysis highlights mixed signals for credit holders. As a positive, management members are material owners of PBF equity relative to their annual compensation,...

Sarepta Therapeutics Inc: 1 director

A director at Sarepta Therapeutics Inc sold 3,635 shares at 140.000USD and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 4, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: May 2, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution ...

PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) (TASE: PFLT) declares its monthly distribution for May 2024 of $0.1025 per share, payable on June 3, 2024 to stockholders of record as of May 15, 2024. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodi...

 PRESS RELEASE

Axogen, Inc Reports First Quarter 2024 Financial Results

Axogen, Inc Reports First Quarter 2024 Financial Results ALACHUA, Fla. and TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the first quarter ended March 31, 2024. First Quarter Financial Results First quarter revenue was $41.4 million, a 12.9% increase compared to the first quarter of 2023.In the first quarter of 2024, our gross margin increased to 78.8%, up from 77.7%, as reclassified* in the sam...

 PRESS RELEASE

Ocwen Financial Announces First Quarter 2024 Results

Ocwen Financial Announces First Quarter 2024 Results Net income of $30 million and diluted earnings per share of $3.74; annualized return on equity of 29%Adjusted pre-tax income of $14 million, driven by servicing segment; achieved 13.8% annualized adjusted pre-tax return on equityRepurchased $47 million in PHH senior secured notes below par$23 billion in total servicing additions ($19 billion in subservicing additions)Moody’s Ratings upgraded corporate family rating to B3 in April 2024 WEST PALM BEACH, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Ocwen Financial Corporation (NYSE: OCN) (“Oc...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2024 05 01

Valens Credit Research team highlights PBF which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

 PRESS RELEASE

New Mountain Finance Corporation Announces Financial Results for the Q...

NEW YORK--(BUSINESS WIRE)-- New Mountain Finance Corporation (NASDAQ: NMFC) (“New Mountain,” “New Mountain Finance” or the “Company”) today announced its financial results for the quarter ended March 31, 2024. First Quarter Highlights1 Net investment income of $37.3 million, or $0.36 per weighted average share Net asset value of $12.77 per share compared to $12.87 per share as of December 31, 2023. The 0.8% decline is driven by stable core credit performance, offset by a decrease in value in one of the Company's equity positions Internal risk rating improved with 96.5% of the portfo...

 PRESS RELEASE

Upwork Reports First Quarter 2024 Financial Results

Upwork Reports First Quarter 2024 Financial Results First-quarter GAAP Net Income of $18.4 million First-quarter GAAP Diluted EPS of $0.13 First-quarter Adjusted EBITDA of $33.3 million Raises revenue and Adjusted EBITDA outlook for 2024 Establishes five-year Adjusted EBITDA margin target of 35% SAN FRANCISCO, May 01, 2024 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the world’s largest work marketplace that connects businesses with independent talent from across the globe, today announced its financial results for the first quarter of 2024. “We drove strong ...

 PRESS RELEASE

Conduent Reports First Quarter 2024 Financial Results

Conduent Reports First Quarter 2024 Financial Results Key Q1 2024 Highlights Revenue: $921MPre-tax Income: $127MAdj. EBITDA Margin(1): 7.5%New business signings ACV(2): $99MNet ARR Activity Metric(2) (TTM): $17M FLORHAM PARK, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Conduent (NASDAQ: CNDT), a global technology-led business process solutions and services company, today announced its first quarter 2024 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “Q1 2024 is a continued reflection of progress in our portfolio performance overlaid by t...

 PRESS RELEASE

Upwork Introduces Upwork Updates to Launch AI Innovations and Other So...

Upwork Introduces Upwork Updates to Launch AI Innovations and Other Solutions Shaping How Businesses and Freelancers Hire and Work First-ever installment of Upwork Updates headlined by Uma, Upwork’s Mindful AI, helping customers work smarter SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: UPWK), the world’s work marketplace that connects businesses with independent talent, today unveiled a collection of products, features and partnerships to transform how businesses and professionals hire and work, as part of , Upwork’s new semi-annual product showcase. Introducing Uma, Upw...

 PRESS RELEASE

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™ ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, Avive+ Soft Tissue Matrix™. “We are excited to expand our offering in nerve protection with the introduction of this resorbable barrier to support the critical phases of healing for nerve injuries,” said Karen Zaderej, chairman, CEO, and president. “We are ...

 PRESS RELEASE

Ocwen Financial Schedules Conference Call – First Quarter 2024 Results...

Ocwen Financial Schedules Conference Call – First Quarter 2024 Results and Business Update WEST PALM BEACH, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- Ocwen Financial Corporation (NYSE: OCN) (“Ocwen” or the “Company”), a leading non-bank mortgage servicer and originator, today announced that it will hold a conference call on Thursday, May 2, 2024 at 8:30 a.m. (ET) to review the Company’s first quarter 2024 operating results and provide a business update. All interested parties are welcome to participate. You can access the conference call by dialing (800) 343-4849 or (203) 518-9848 approxi...

General Electric Company: Key facts and statistics - 2023

A summary company profile, detailing General Electric Company’s business operations and financial highlights.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch